Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Gadolinium
texaphyrin may increase the effectiveness of radiation therapy by making tumor cells more
sensitive to radiation. It is not yet known whether giving gadolinium texaphyrin with
radiation therapy is more effective than radiation therapy alone in treating brain
metastases.
PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or
without gadolinium texaphyrin in treating patients who have brain metastases.